CIK 0001746473 · Non-accelerated filer<br>Smaller reporting company
PLIANT THERAPEUTICS, INC.
Sign in to watch- Ticker
- PLRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 474272481
- Phone
- 650-481-6770
- Business address
- 331 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA, 94080
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Option exercise Chief Financial Officer acquired 21,000 shares (option exercise)
- 4 Grant or award Chief Medical Officer acquired 42,900 shares (grant or award)
- 4 Grant or award Chief Business Officer acquired 31,500 shares (grant or award)
- 4 Grant or award General Counsel & Corp. Sec'y acquired 31,500 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 55,250 shares (grant or award)
- 4 Grant or award Chief Human Resource Officer acquired 26,000 shares (grant or award)
- 4 Grant or award President and CEO acquired 128,150 shares (grant or award)
- 4 Planned sale Chief Financial Officer sold 9,781 shares at $17.23 ($168,527)
- 4 Planned sale Chief Business Officer sold 9,786 shares at $17.23 ($168,613)
- 4 Planned sale President and CEO sold 25,721 shares at $17.23 ($443,173)
- 4 Planned sale Chief Medical Officer sold 10,295 shares at $17.23 ($177,383)
- 4 Planned sale General Counsel & Corp. Sec'y sold 5,197 shares at $17.23 ($89,544)
- 4 Planned sale Chief Business Officer sold 33,119 shares at an average $20.01 ($662,581)
Page 4 of 11 · 215 filings